Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v8-EN
Language English English
Date Updated 2022-04-02 2022-02-08
Drug Identification Number 01999869 01999869
Brand name KENALOG-40 INJECTION 40MG/ML KENALOG-40 INJECTION 40MG/ML
Common or Proper name Triamcinolone Acetonide Triamcinolone Acetonide
Company Name BRISTOL-MYERS SQUIBB CANADA BRISTOL-MYERS SQUIBB CANADA
Ingredients TRIAMCINOLONE ACETONIDE TRIAMCINOLONE ACETONIDE
Strength(s) 40MG 40MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRA-ARTICULAR INTRAMUSCULAR INTRA-ARTICULAR INTRAMUSCULAR INTRA-ARTICULAR INTRAMUSCULAR INTRA-ARTICULAR
Packaging size 5mL 5mL
ATC code H02AB H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-03-15 2022-02-09
Actual start date
Estimated end date 2022-04-01 Unknown
Actual end date 2022-04-01
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments